BOFAS News & Events

This pages lists all the latest news and upcoming events.

 

To access 'Foot Print' (the BOFAS Bulletin) please click here (members only)

 

Latest News

Annual Meeting 2021 - Recap

The 2021 Annual Meeting is over, but click here if you missed it!

We hope you enjoyed the 2021 Virtual Annual meeting, but if you could not make it, it's available for members free of charge! Follow the link to view the programme and recordings. 

12345678

 

BOFAS Hosted Events

BOFAS Principles Course - Dubai

The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery.

There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab.

This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area.

Venue - Le Meridien, Dubai, United Arab Emirates

Documents to download

BOFAS Principles Course Taunton

These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023.

Venue - Taunton (TBC)

 

 

Documents to download


 

BOFAS Affiliated Courses

Other External Events / Courses

Togay Koç
/ Categories: Abstracts, 2014, Podium

Corticosteroid injections for Morton's neuroma - does ultrasound guidance improve efficacy? A randomised controlled trial

D. Mahadevan, R. Bhatt, M. Bhatia

Background: The purpose of this double-blind randomised controlled trial was to assess whether ultrasound guidance improved the efficacy of steroid injections for Morton's neuroma (MN).

Methods: Following IRB approval, cases with MN confirmed on ultrasound were randomised to 2 groups: Group 1 received ultrasound-guided injections (1ml 40mg Depo-Medrone and 1ml 1% lignocaine) and Group 2 received the same injection under sham ultrasound guidance. All ultrasounds and injections were performed by a single MSK radiologist. Patients were reviewed at 3 months.
The primary outcome measure was the VAS for pain. The study was powered to detect a MCID of 15mm on a 100mm VAS scale between the groups (21 per group). Secondary outcomes included the Manchester-Oxford Foot Questionnaire (MOxFQ), Johnson's satisfaction scale and failure of treatment.

Results: 50 cases (feet) were recruited for this study. Demographics included 29 female to 21 male with a mean age of 58 years (29 - 88 yr). Five cases declined further participation and were excluded from analysis. The VAS score improved significantly in both groups (64 to 25mm in Group 1 vs. 67 to 34mm in Group 2; p< 0.005) but there was no significant difference between the groups (p=0.08). Similarly, the improvement in MOxFQ scores was also significant in both groups (38 to 18 in Group 1 vs. 38 to 23 in Group 2; p< 0.05) but did not reach statistical significance when the groups were compared (p=0.086). The Johnson's satisfaction scale was however, significantly better in Group 1 (p=0.011). Seventy-percent in Group 1 were either completely satisfied/ satisfied with minor reservation compared to only 50% in Group 2. At 3 months, 17% in Group 1 versus 36% in Group 2 failed treatment.

Conclusion: The results suggest that the use of ultrasound guidance improved the efficacy of steroid injections for symptomatic Morton's neuroma.

 

Print
770